CoChat

The impact of Type 2 diabetes prevention programmes based on risk‐identification and lifestyle intervention intensity strategies: a cost‐effectiveness analysis

Open access
Breeze, P. R., Thomas, C., Squires, H., Brennan, A., Greaves, C., Diggle, P. J., Brunner, E., Tabak, A., Preston, L., Chilcott, J. · 2017 · Diabetic Medicine
Cited by 50

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aims: To develop a cost‐effectiveness model to compare Type 2 diabetes prevention programmes targeting different at‐risk population subgroups with a lifestyle intervention of varying intensity. Methods: An individual patient simulation model was constructed to simulate the development of diabetes in a representative sample of adults without diabetes from the UK population. The model incorporates trajectories for HbA 1c, 2‐h glucose, fasting plasma glucose, BMI, systolic blood pressure, total cholesterol and HDL cholesterol. Patients can be diagnosed with diabetes, cardiovascular disease, microvascular complications of diabetes, cancer, osteoarthritis and depression, or can die. The model collects costs and utilities over a lifetime horizon. The perspective is the UK National Health Service and personal social services. We used the model to evaluate the population‐wide impact of targeting a lifestyle intervention of varying intensity to six population subgroups defined as high risk for diabetes. Results: The intervention produces 0.0003 to 0.0009 incremental quality‐adjusted life years and saves up to £1.04 per person in the general population, depending upon the subgroup targeted. Cost‐effectiveness increases with intervention intensity. The most cost‐effective options are to target individuals with HbA 1c > 42 mmol/mol (6%) or with a high Finnish Diabetes Risk (FINDRISC) probability score (> 0.1). Conclusion: The model indicates that diabetes prevention interventions are likely to be cost‐effective and may be cost‐saving over a lifetime. In the model, the criteria for selecting at‐risk individuals differentially impact upon diabetes and cardiovascular disease outcomes, and on the timing of benefits. These findings have implications for deciding who should be targeted for diabetes prevention interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.13314

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Breeze, P. R., Thomas, C., Squires, H., Brennan, A., Greaves, C., Diggle, P. J., Brunner, E., Tabak, A., Preston, L., & Chilcott, J.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2017-03-10
Volume
34
Issue
5
Pages
632-640
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2095942727
Cited by
50
References
8
FWCI
7.32
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.